Funds holding Enliven Therapeutics Inc
ISIN US29337E1029 · United States
- Fund holders
- 226
- Of which ETFs
- 50 176 other funds
- Value held
- 1B $
- Share of capital
- 27.3 % of 73.3M shares on Jul 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 589 | 29.9K $ | 0.16 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 580 | 31.8K $ | 0.18 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 569 | 31.2K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 551 | 30.2K $ | 0.05 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 511 | 25.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 423 | 23.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 413 | 22.6K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 352 | 17.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 290 | 15.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 230 | 11.7K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 222 | 11.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 200 | 11K $ | 0.10 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 196 | 9.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 178 | 9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 176 | 8.9K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 170 | 9.3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 115 | 5.8K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 106 | 5.4K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 80 | 4.1K $ | 0.11 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 72 | 3.7K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 63 | 3.2K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 37 | 1.5K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 36 | 2K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 23 | 1.3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 12 | 609 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 474.8 $ | 0.04 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| CapForce IBD Breakout Opportunities ETF Capital Force ETF Trust | 7.26 % | as of Jul 31, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 2.34 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 2.09 % | as of Jun 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 2.03 % | as of Jun 30, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 1.71 % | as of Jun 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.70 % | as of Jul 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.68 % | as of Jul 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.59 % | as of Jul 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.31 % | as of May 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 1.25 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 226 | +52 | 20,010,590 | +46.5 % |
| 2026Q2 | 174 | +19 | 13,658,962 | -7.4 % |
| 2026Q1 | 155 | +4 | 14,744,562 | +3.1 % |
| 2025Q4 | 151 | +7 | 14,296,096 | +12.5 % |
| 2025Q3 | 144 | -9 | 12,711,510 | +23.2 % |
| 2025Q2 | 153 | +7 | 10,318,195 | +0.4 % |
| 2025Q1 | 146 | +2 | 10,273,848 | +5.0 % |
| 2024Q4 | 144 | +16 | 9,782,919 | +13.6 % |
| 2024Q3 | 128 | +19 | 8,614,500 | +5.3 % |
| 2024Q2 | 109 | +6 | 8,179,416 | +10.6 % |
| 2024Q1 | 103 | +1 | 7,396,819 | +14.0 % |
| 2023Q4 | 102 | 6,489,084 |
Institutional managers
168 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7,959,538 | 312M $ | as of Mar 31, 2026 |
| FMR LLC | 6,829,246 | 267.7M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 5,065,933 | 198.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,684,707 | 144.4M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 3,275,000 | 128.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 3,250,000 | 127.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,320,867 | 91M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,168,162 | 85M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 1,855,644 | 72.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,743,915 | 68.4M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 1,726,331 | 67.7M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,280,000 | 50.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,091,106 | 42.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,066,420 | 41.8M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 929,544 | 36.4M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 905,191 | 35.5M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 826,500 | 32.4M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 771,885 | 11.9M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 746,226 | 29.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 681,715 | 26.7M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 623,839 | 24.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 594,079 | 23.3M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 593,040 | 23.2M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 586,904 | 23M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 540,000 | 21.2M $ | as of Mar 31, 2026 |
Declared shareholders of Enliven Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 15.00 % | 10,713,540 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Enliven Therapeutics Inc". https://titelia.com/en/stocks/enliven-therapeutics-inc-US29337E1029